Metabolic syndrome: yet another co-morbidity gastric bypass helps cure

Surgery for Obesity and Related Diseases

Volumn 2, Issue 1, 2006, Pages 48-51

  Madan, Atul K ^a,b   Orth, Whitney ^b   Ternovits, Craig A ^a   Tichansky, David S ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b METHODIST UNIVERSITY HOSPITAL   (United States)

Author keywords

Bariatric surgery; Laparoscopic gastric bypass; Metabolic syndrome; Morbid obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH BYPASS; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ANASTOMOSIS, ROUX-EN-Y; BODY MASS INDEX; COMORBIDITY; FEMALE; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; MALE; METABOLIC SYNDROME X; OBESITY, MORBID; RETROSPECTIVE STUDIES;

EID: 33646438528     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2005.09.014     Document Type: Article

References (14)

1. Studien K.E. Hypertonie-hyperglykamie-hyperurikamiesyndrome. Zentralblatt fur innere Medizin 44 (1923) 105-127
2. Vague J. La differenciation sexuelle, facteur determinant des formes de l'obesite. Presse Med 30 (1947) 339-340
3. Reaven G.M. Banting lecture 1988. role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
4. DeFronzo R.A., and Ferrannini E. Insulin resistance. a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
5. Kaplan N.M. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149 (1989) 1514-1520
6. Case C.C., Jones P.H., Nelson K., Smith E.O., and Ballantyne C. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 4 (2002) 407-414
7. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery. a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
8. Maggard M.A., Shugarman L.R., Suttorp M., et al. Meta-analysis. surgical treatment of obesity. Ann Intern Med 142 (2005) 547-559
9. Sjostrom L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
10. Lee W.J., Huang M.T., Wang W., Lin C.M., Chen T.C., and Lai I.R. Effects of obesity surgery on the metabolic syndrome. Arch Surg 139 (2004) 1088-1092
11. Gazzaruso C., Giordanetti S., Manna A.L., et al. Weight loss after Swedish adjustable gastric banding. relationships to insulin resistance and metabolic syndrome. Obes Surg 12 (2002) 841-845
12. Giusti V., Suter M., Heraief E., Gaillard R.C., and Burckhardt P. Effects of laparoscopic gastric banding on body composition, metabolic profile and nutritional status of obese women. 12-months' follow-up. Obes Surg 14 (2004) 239-245
13. Jimenez A.L., Cabezudo C.S., Borrajo P.P., Garcia I.R., Esteban B.M., and Robles R.G. Course of metabolic syndrome following the biliopancreatic diversion of Larrad. Obes Surg 14 (2004) 1176-1180
14. Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Consensus Development Conference statement. Ann Intern Med 115 (1991) 956-961